|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
676 a.a.
|
 |
|
|
|
|
|
|
|
174 a.a.
|
 |
|
|
|
|
|
|
|
56 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Calcium-dependent complex between m-calpain and calpastatin
|
|
Structure:
|
 |
Calpain-2 catalytic subunit. Chain: a. Synonym: calpain-2 large subunit, calcium-activated neutral proteinase 2, canp 2, calpain m-type, m-calpain, millimolar-calpain. Engineered: yes. Mutation: yes. Calpain small subunit 1. Chain: b. Fragment: unp residues 87-270.
|
|
Source:
|
 |
Rattus norvegicus. Rat. Organism_taxid: 10116. Gene: capn2. Expressed in: escherichia coli. Gene: capns1, capn4, css1. Gene: cast.
|
|
Resolution:
|
 |
|
2.95Å
|
R-factor:
|
0.232
|
R-free:
|
0.299
|
|
|
Authors:
|
 |
T.Moldoveanu,K.Gehring,D.R.Green
|
Key ref:
|
 |
T.Moldoveanu
et al.
(2008).
Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains.
Nature,
456,
404-408.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
11-Jun-08
|
Release date:
|
11-Nov-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q07009
(CAN2_RAT) -
Calpain-2 catalytic subunit from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
700 a.a.
676 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain A:
E.C.3.4.22.53
- calpain-2.
|
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Ca(2+)
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains B, C:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
456:404-408
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains.
|
|
T.Moldoveanu,
K.Gehring,
D.R.Green.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Ca(2+)-dependent cysteine proteases, calpains, regulate cell migration, cell
death, insulin secretion, synaptic function and muscle homeostasis. Their
endogenous inhibitor, calpastatin, consists of four inhibitory repeats, each of
which neutralizes an activated calpain with exquisite specificity and potency.
Despite the physiological importance of this interaction, the structural basis
of calpain inhibition by calpastatin is unknown. Here we report the 3.0 A
structure of Ca(2+)-bound m-calpain in complex with the first calpastatin
repeat, both from rat, revealing the mechanism of exclusive specificity. The
structure highlights the complexity of calpain activation by Ca(2+),
illustrating key residues in a peripheral domain that serve to stabilize the
protease core on Ca(2+) binding. Fully activated calpain binds ten Ca(2+) atoms,
resulting in several conformational changes allowing recognition by calpastatin.
Calpain inhibition is mediated by the intimate contact with three critical
regions of calpastatin. Two regions target the penta-EF-hand domains of calpain
and the third occupies the substrate-binding cleft, projecting a loop around the
active site thiol to evade proteolysis.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1: Complex between Ca^2+-bound m-calpain and calpastatin.
a, Overall structure shows regions A, B and C of calpastatin
bound to DIV, DI–III and DVI of calpain, respectively. The
intervening sequences of calpastatin are devoid of electron
density (red dots). The central part of the inhibitory region B
forms the occluding loop at the active site. The active site in
the protease core DI–II is stabilized by DIII. Calpain
heterodimerization is largely defined at the DIV–DVI
interface. Alternate conformations at the interface between the
DI–III core and the DIV–DVI heterodimer (black dots) are
possible^30. b, ^15N,^1H-HSQC (heteronuclear single quantum
correlation) spectrum of the complex between ^13C,^15N-labelled
calpastatin (residues 128–226, Supplementary Fig. 2b) and
unlabelled calpain identified flexible/disordered residues of
calpastatin. Connected sample strips from the HNCA NMR
experiment are inset.
|
 |
Figure 4.
Figure 4: Calpain–calpastatin proteolytic system. A
schematic diagram illustrating the Ca^2+-induced activation of
calpain and its inhibition by calpastatin. DIII has a
fundamental role in relaying the Ca^2+-induced structural
changes (red dotted arrows) from the peripheral domains to the
catalytically competent yet labile protease core. Concerted
binding of the intrinsically unstructured protein (IUP)
calpastatin to peripheral domains and the active site of calpain
results in low-nanomolar inhibition.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(2008,
456,
404-408)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.J.Storr,
N.O.Carragher,
M.C.Frame,
T.Parr,
and
S.G.Martin
(2011).
The calpain system and cancer.
|
| |
Nat Rev Cancer,
11,
364-374.
|
 |
|
|
|
|
 |
A.de Morrée,
D.Lutje Hulsik,
A.Impagliazzo,
H.H.van Haagen,
P.de Galan,
A.van Remoortere,
P.A.'t Hoen,
G.B.van Ommen,
R.R.Frants,
and
S.M.van der Maarel
(2010).
Calpain 3 is a rapid-action, unidirectional proteolytic switch central to muscle remodeling.
|
| |
PLoS One,
5,
e11940.
|
 |
|
|
|
|
 |
C.J.Farady,
and
C.S.Craik
(2010).
Mechanisms of macromolecular protease inhibitors.
|
| |
Chembiochem,
11,
2341-2346.
|
 |
|
|
|
|
 |
H.Sorimachi,
S.Hata,
and
Y.Ono
(2010).
Expanding members and roles of the calpain superfamily and their genetically modified animals.
|
| |
Exp Anim,
59,
549-566.
|
 |
|
|
|
|
 |
J.L.Fuentes,
M.S.Strayer,
and
A.G.Matera
(2010).
Molecular determinants of survival motor neuron (SMN) protein cleavage by the calcium-activated protease, calpain.
|
| |
PLoS One,
5,
e15769.
|
 |
|
|
|
|
 |
M.Montal
(2010).
Botulinum neurotoxin: a marvel of protein design.
|
| |
Annu Rev Biochem,
79,
591-617.
|
 |
|
|
|
|
 |
Y.Osako,
Y.Maemoto,
R.Tanaka,
H.Suzuki,
H.Shibata,
and
M.Maki
(2010).
Autolytic activity of human calpain 7 is enhanced by ESCRT-III-related protein IST1 through MIT-MIM interaction.
|
| |
FEBS J,
277,
4412-4426.
|
 |
|
|
|
|
 |
Z.Dosztányi,
B.Mészáros,
and
I.Simon
(2010).
Bioinformatical approaches to characterize intrinsically disordered/unstructured proteins.
|
| |
Brief Bioinform,
11,
225-243.
|
 |
|
|
|
|
 |
O.Toke,
Z.Bánóczi,
G.Tárkányi,
P.Friedrich,
and
F.Hudecz
(2009).
Folding transitions in calpain activator peptides studied by solution NMR spectroscopy.
|
| |
J Pept Sci,
15,
404-410.
|
 |
|
|
|
|
 |
R.Chandramohanadas,
P.H.Davis,
D.P.Beiting,
M.B.Harbut,
C.Darling,
G.Velmourougane,
M.Y.Lee,
P.A.Greer,
D.S.Roos,
and
D.C.Greenbaum
(2009).
Apicomplexan parasites co-opt host calpains to facilitate their escape from infected cells.
|
| |
Science,
324,
794-797.
|
 |
|
|
|
|
 |
S.A.Woodcock,
C.Rooney,
M.Liontos,
Y.Connolly,
V.Zoumpourlis,
A.D.Whetton,
V.G.Gorgoulis,
and
A.Malliri
(2009).
SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1.
|
| |
Mol Cell,
33,
639-653.
|
 |
|
|
|
|
 |
R.L.Mellgren
(2008).
Structural biology: Enzyme knocked for a loop.
|
| |
Nature,
456,
337-338.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|